COVID-19: Poison Control Calls Up; Ultomiris Trial; Lab Protocol Failures

Inbox

x

MPR Daily Dose <editor@email.empr.com> Unsubscribe

3:14 AM (18 hours ago)

to me

If you are having trouble viewing this email, click here.

MUST READS Pemazyre Approved for Unresectable Locally Advanced or Metastatic Cholangiocarcinoma CDC: Poison Control Calls for Cleaning Product Incidents Up During Pandemic Ultomiris to Be Evaluated for Severe COVID-19 in Phase 3 Trial Lab Protocol Failures Led to Ineffective COVID-19 Tests From CDC FDA to Review Data on Shorter Infusion Time for MS Drug Ocrevus FEATURES Is a Doctor-Patient Relationship a Necessary Element for a Claim of Medical Malpractice? Featured Content 5 FACTS ABOUT REAL-WORLD DATA Conducting real-world data analyses to generate real-world evidence is becoming increasingly common. What are the applications and limitations of this practice? Find Out Now. CME/CE Spotlight Are Your Patients Using the Most Effective Contraceptive Methods for Them? AMA PRA Category 1 Credit(s)TM CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME